Combination Products Raise Manufacturing Challenges

New fixed-dose combination drugs aim to enhance safety and efficacy, while regulators clear a path for more drug–device combination products.

Related Content:

FormulationSolid/Semi-Solid DosageManufacturingQuality SystemsRegulatory WatchDosage FormsManufacturing, Solid Dosage DrugsPharmaceutical Technology-03-02-2005

Congress Slated to Reauthorize User Fees without FDA “Improvements”

The Manufacturing Edge on Path to Market

FDA Approves Bluebird Bio’s $3 Million CALD Treatment